.avif)
Seagen Email Format
Biotechnology Research
・
1,001-2,500 employees
・
Bothell, WA, USA
Seagen is a biotechnology company specializing in antibody-drug conjugate technology for the development of life-saving cancer treatments, now part of Pfizer.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@seagen.com
Company Overview
Industry
Biotechnology Research
Founded
1998
Headquarters
Bothell, WA, USA
Revenue
$500M-$1B
FUNDING Stage
Acquired
Website
Key Executives
Dave Denton (Chief Financial Officer and Executive Vice President), Vaughn B. Himes (Chief Technical Officer), Charles "Chip" R. Romp (Executive Vice President Commercial)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Seagen?
Seagen uses the firstinitiallast format, so Jane Smith would be jsmith@seagen.com.
What approved cancer drugs did Seagen bring to market?
Seagen developed four FDA-approved oncology medicines: ADCETRIS for Hodgkin lymphoma, PADCEV for bladder cancer, TIVDAK for cervical cancer, and TUKYSA for HER2-positive breast and colorectal cancers, all of which are now part of Pfizer's oncology portfolio.
How does Seagen's antibody-drug conjugate technology work?
Seagen pioneered ADC technology that links a monoclonal antibody to a cell-killing payload, delivering chemotherapy directly to cancer cells. Its vedotin platform, based on the MMAE payload, underpins four FDA-approved ADCs and has been licensed to multiple global partners.
Where is Seagen headquartered and what happens at its main campus?
Seagen is headquartered in Bothell, Washington, on a 500,000-plus square foot campus now operated by Pfizer and dedicated to oncology research and cancer therapy development. If you need to reach specific contacts there, Clay can help you find and verify the right Seagen email addresses.
When was Seagen founded and who started the company?
Seagen was founded in 1997 in Bothell, Washington, by Clay Siegall and Henry Perry Fell Jr. under the name Seattle Genetics. The company changed its name to Seagen in 2020 before being acquired by Pfizer in December 2023 for approximately 43 billion dollars.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating